Evidence map›Paper›PMID 31312361›Full record

ArticleAmerican journal of translational research2019

Real-time observation of pancreatic beta cell differentiation from human induced pluripotent stem cells.

Qiwei Wang, William Donelan, Huahu Ye, Yulan Jin, Yanli Lin, Xiaojie Wu, Youliang Wang, Yongyi Xi

Abstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Neural Stem Cell-based Regenerative Therapy: A New Approach to Diabetes Treatment.Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiwei WangCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.
William DonelanDepartment of Urology, University of Florida Gainesville, Florida 32610, USA.
Huahu YeCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.
Yulan JinDepartment of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing 100006, P. R. China.
Yanli LinCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.
Xiaojie WuCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.
Youliang WangCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.
Yongyi XiCell Engineering Laboratory, Beijing Institute of Biotechnology 20 Dongda Street, Fengtai District, Beijing 100071, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Directed differentiation of human pluripotent stem cells (hPSCs) into functional insulin-producing cells (IPCs) holds great promise for cell therapy for diabetic patients. Despite recent advances in developing beta cell differentiation protocols, it is becoming clear that the hPSC-derived beta-like cells are functionally immature, and the efficiencies of differentiation can be variable depending on the hPSC lines used. Therefore, advanced methodologies are highly desirable for the development and refinement of beta cell differentiation protocols from hPSCs. In this report, we first derived and validated a Pdx1-mRFP/insulin-hrGFP dual-reporter cell line from MRC5-iPSCs. Then, using this dual-reporter cell line, we developed and optimized an

Indexed as

beta cell differentiationdiabetesInduced pluripotent stem cellsPdx1/insulin dual-reporterreal-time monitoring

Identifiers

PMID31312361
PMCPMC6614661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.